US Broker Ratings

MiMedx Group, Inc (MDXG) Stock Analysis: Significant Upside with 98.10% Potential Growth Awaits Investors

MiMedx Group, Inc. (NASDAQ: MDXG), a prominent player in the biotechnology sector specializing in healthcare solutions, stands out in the market with a compelling proposition for..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 12.62% Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG) presents an intriguing opportunity for investors within the healthcare sector. With a market capitalization of $1.38 billion, this Pennsylvania-based company..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating a 42% Potential Upside Amidst Financial Volatility

Teladoc Health, Inc. (NYSE: TDOC), a leader in the virtual healthcare space, presents a unique investment opportunity characterized by significant potential upside and a challenging financial..

Harrow, Inc. (HROW) Stock Analysis: Unveiling a 61% Upside Potential in the Eye Care Pharma Sector

Harrow, Inc. (NASDAQ: HROW) is making waves in the healthcare sector, particularly within the specialized realm of ophthalmic pharmaceuticals. With a market capitalization of $1.62 billion,..

Phreesia, Inc. (PHR) Stock Analysis: Navigating an 82% Potential Upside in the Healthcare SaaS Market

Phreesia, Inc. (NYSE: PHR) has been capturing attention in the healthcare technology sector with its robust SaaS-based platform that streamlines operations across the healthcare industry. With..

Establishment Labs Holdings (ESTA) Stock Analysis: Exploring a 27.88% Potential Upside Amid Robust Revenue Growth

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a Costa Rica-based innovator in the medical devices sector, is capturing investor interest with its impressive revenue growth and substantial..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a Promising 16.84% Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS), a prominent player in the healthcare sector, is capturing investor attention with its innovative approach to cardiovascular disease management. Based in..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a 334% Potential Upside with Innovative Cancer Therapies

Janux Therapeutics, Inc. (NASDAQ: JANX), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its ambitious quest to revolutionize cancer treatment...

Indivior PLC (INDV) Stock Report: Strong Buy Ratings and 35.71% Upside Potential

Indivior PLC (INDV), a key player in the healthcare sector, specializes in developing and manufacturing buprenorphine-based prescription drugs aimed at treating opioid dependence and related disorders...

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook with 22.91% Potential Upside

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) presents a compelling opportunity for investors interested in the healthcare sector, particularly with its promising upside potential of 22.91%. As..

Adaptive Biotechnologies Corporation (ADPT): Investor Outlook with a 102.40% Revenue Growth Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) has caught the attention of investors with its impressive revenue growth of 102.40% over the past year. As a leading player..

The Pennant Group (PNTG) Stock Analysis: Exploring a 22.79% Upside in the Healthcare Sector

The Pennant Group, Inc. (PNTG), operating in the dynamic healthcare sector, has been gaining traction among investors, largely due to its solid growth potential and promising..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 63% Upside Potential in Biotech Innovation

Biohaven Ltd. (BHVN) is making waves in the biotechnology sector with its ambitious pipeline of treatments targeting neurological, psychiatric, and oncological diseases. With a market capitalization..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring 37% Upside Potential in the Medical Instruments Sector

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector, offers a compelling investment opportunity with a substantial potential upside of 37.05%, according to analyst..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 36% Upside Potential in the Biotechnology Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is currently capturing the attention of investors with a robust potential upside of 36.21%. As a biopharmaceutical innovator in the healthcare..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 16% Potential Upside in the Diagnostics & Research Sector

NeoGenomics, Inc. (NASDAQ: NEO), a leader in the diagnostics and research industry with a specialization in cancer-focused testing laboratories, presents an intriguing opportunity for investors seeking..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a Potential 18.69% Upside for Investors

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a leading player in the drug manufacturing sector, particularly in specialty and generic segments, has been attracting the attention of investors..

LivaNova PLC (LIVN) Stock Analysis: Navigating Market Growth with a 13.71% Potential Upside

LivaNova PLC (LIVN), a key player in the healthcare sector specializing in medical devices, has caught the attention of investors with its solid performance and promising..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring the 17% Potential Upside for Investors

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Switzerland-based biotechnology company, has captured investor attention with its ambitious focus on developing innovative therapies for inflammatory skin and joint diseases...

Veracyte, Inc. (VCYT) Stock Analysis: A Diagnostic Leader with 17.49% Potential Upside

Veracyte, Inc. (VCYT), a leading player in the healthcare sector, stands out in the diagnostics and research industry with its innovative genomic tests. Headquartered in South..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds